IRW-Press: Haldane McCall PLC Provisional Profit Increases By 139% Compared To 2011

by Press Office

(IRW-PRESS and WireNews+Co) - Vienna, Austria - 26 October 2012

Haldane McCall PLC (Frankfurt: WKN A1J3U8, HMK1), a European company that invests in emerging markets in Africa, provides a corporate update to report on current developments within the company.

Sales in the Emerging Market of Nigeria grew rapidly and the business activities are expanding. The company works solid and reliable as usual. Profitability increased significantly. The interim profit for the first 9 months of 2012 increased compared to the 9-month figures for 2011 by 139 percent.

In comparison:
9 months 9 months changes
ended 30.09.2011 ended 30.09.2012 in percent

profit before tax 3.024.000 Euro 7.234.000 Euro + 139 %
profit after tax 2.419.000 Euro 5.788.000 Euro + 139 %
return on sales 12 % 32 %
Liabilities 57.709.000 Euro 42.025.000 Euro - 27 %
net assets 73.116.000 Euro 78.766.000 Euro + 7,7 %

In total the financial year 2012 runs very satisfyingly. Cost savings according to plan could be realized, the occupancy rate of the hotels increased by 4.25% in comparison to the previous year, another hotel of own Suru Express chain was opened in Lagos in August and is now contributing to the sales increase.

After a successful reverse split on 12. September 2012, the number of shares is reduced to a maximum of 56,670,436 common shares and 400,000 preferred shares.

In 2013, the company plans to have major advances and corresponding increase in sales.

In January 2013, the company starts the construction of 1,000 low costs housing units in Majidun, Lagos. Even now 10% of the fully furnished apartments have been sold. Another project, which the company plans to realize in the coming months, is the $ 10 million leisure center 'Suru F1' in Lagos.

In the hotel sector in 2013, the company plans to expand the hotel chain to Abuja. Also for this reason, the company will be represented in November 2012 on the world's largest travel trade event 'WTM - World Travel Market' (http://www.wtmlondon.com) in London. Besides the presentation of their own hotels, contacts and strategic partnerships with other African hotels should be also concluded.

Prolific Micro Finance Bank will commence on-lending to other bank at 2.5% per month fully secure commencing January 2013. This will lead to further revenue and earnings growth in 2013. This was approved by the board.

The company is still on track to meet all the requirements for the Entry standard upgrade of the Frankfurt stock exchange. A prospectus is already filed with BaFin. And FSElaw the commissioned solicitor is in dialogue with BaFin to take care of all issues regarding having an approved prospectus. In addition, the company in 2013 plans a Listing on the London stock exchange.

Further announcement will be made by the company.

About HMK
Haldane McCall PLC is a European Company investing in emerging markets, primarily in Africa. HMK invests in real estate in the low cost housing segment in West Africa. The Group operates the Best Western hotel brand in West Africa. The Company owns Best Western hotels and controls several others via franchise licensing in Nigeria. HMK operates own Suru Express hotels in West Africa. HMK has dedicated subsidiaries for real estate (Suru Homes Ltd.) and dedicated financial services (Prolific Micro Finance Bank Ltd.) to provide a full package -from financing to sale- to the lower income population in Africa. In addition HMK invests in real estate and hotels in selected European metropolises.

Please send enquiries to: info@haldanemccallplc.com (http://www.wirenews.co/mailto:info@haldanemccallplc.com)
Visit our website: www.haldanemccallplc.com (http://www.haldanemccallplc.com)

Safe Harbor Statement: The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time.